EWS-ETS oncoproteins: The linchpins of Ewing tumors

Gene

Volumn 363, Issue 1-2, 2005, Pages 1-14

  Janknecht, Ralf ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cancer; Ewing's sarcoma protein; FUS; Gene transcription; RNA splicing

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; E2S TRANSFORMATION SPECIFIC PROTEIN; HYBRID PROTEIN; IMATINIB; ONCOPROTEIN; PROTEIN TYROSINE KINASE INHIBITOR; RAPAMYCIN; RNA BINDING PROTEIN EWS; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; COLORECTAL CANCER; DNA BINDING; EWING SARCOMA; GENE EXPRESSION; GENE TARGETING; GROWTH INHIBITION; HUMAN; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RNA SPLICING; SURVIVAL RATE; TRANSCRIPTION REGULATION;

CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 21; HUMANS; PROTO-ONCOGENE PROTEINS C-ETS; RNA-BINDING PROTEIN EWS; SARCOMA, EWING'S; TRANSLOCATION, GENETIC;

EID: 28044468016     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2005.08.007     Document Type: Review

References (232)

1. S.I. Ahmed, A.L. Thomas, and W.P. Steward Vascular endothelial growth factor (VEGF) inhibition by small molecules J. Chemother. 16 2004 59 63
2. P. Aman Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS Genomics 37 1996 1 8
3. S. Arber, D.R. Ladle, J.H. Lin, E. Frank, and T.M. Jessell ETS gene Er81 controls the formation of functional connections between group Ia sensory afferents and motor neurons Cell 101 2000 485 498
4. A. Arvand, and C.T. Denny Biology of EWS/ETS fusions in Ewing's family tumors Oncogene 20 2001 5747 5754
5. A. Arvand, S.M. Welford, M.A. Teitell, and C.T. Denny The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1 Cancer Res. 61 2001 5311 5317
6. C. Attwooll, M. Tariq, M. Harris, J.D. Coyne, N. Telford, and J.M. Varley Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma Oncogene 18 1999 7599 7601
7. A. Aurias, C. Rimbaut, D. Buffe, J. Dubousset, and A. Mazabraud Chromosomal translocations in Ewing's sarcoma N. Engl. J. Med. 309 1983 496 497
8. H. Baechtold, M. Kuroda, J. Sok, D. Ron, B.S. Lopez, and A.T. Akhmedov Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation J. Biol. Chem. 274 1999 34337 34342
9. C. Baer Profiling and functional annotation of mRNA gene expression in pediatric rhabdomyosarcoma and Ewing's sarcoma Int. J. Cancer 110 2004 687 694
10. R.A. Bailly DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma Mol. Cell. Biol. 14 1994 3230 3241
11. D.M. Becroft, A. Pearson, R.L. Shaw, and L.J. Zwi Chromosome translocation in extraskeletal Ewing's tumour Lancet 2 1984 400
12. Y. Ben-David, E.B. Giddens, K. Letwin, and A. Bernstein Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1 Genes Dev. 5 1991 908 918
13. A. Bertolotti, Y. Lutz, D.J. Heard, P. Chambon, and L. Tora hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II EMBO J. 15 1996 5022 5031
14. A. Bertolotti, T. Melot, J. Acker, M. Vigneron, O. Delattre, and L. Tora EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes Mol. Cell. Biol. 18 1998 1489 1497
15. A. Bertolotti, B. Bell, and L. Tora The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties Oncogene 18 1999 8000 8010
16. A.R. Black, J.D. Black, and J. Azizkhan-Clifford Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer J. Cell. Physiol. 188 2001 143 160
17. B.B. Bojovic, and J.A. Hassell The PEA3 Ets transcription factor comprises multiple domains that regulate transactivation and DNA binding J. Biol. Chem. 276 2001 4509 4521
18. D.G. Bosc, and R. Janknecht Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81 J. Cell. Biochem. 86 2002 174 183
19. D.G. Bosc, B.S. Goueli, and R. Janknecht HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1 Oncogene 20 2001 6215 6224
20. B.S. Braun, R. Frieden, S.L. Lessnick, W.A. May, and C.T. Denny Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis Mol. Cell. Biol. 15 1995 4623 4630
21. C.E. Brinckerhoff, and L.M. Matrisian Matrix metalloproteinases: a tail of a frog that became a prince Nat. Rev., Mol. Cell Biol. 3 2002 207 214
22. R.I. Brody Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma Am. J. Pathol. 150 1997 1049 1058
23. S.A. Burchill Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities J. Clin. Pathol. 56 2003 96 102
24. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
25. A.O. Cavazzana, J.S. Miser, J. Jefferson, and T.J. Triche Experimental evidence for a neural origin of Ewing's sarcoma of bone Am. J. Pathol. 127 1987 507 518
26. J. Clark Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma Oncogene 12 1996 229 235
27. T.S. Collins, and H.I. Hurwitz Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancer Semin. Oncol. 32 2005 61 68
28. A.S. Corbin Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970 Blood 104 2004 3754 3757
29. S.J. Cotterill, L. Parker, A.J. Malcolm, M. Reid, L. More, and A.W. Craft Incidence and survival for cancer in children and young adults in the North of England, 1968-1995: a report from the Northern region young persons' malignant disease registry Br. J. Cancer 83 2000 397 403
30. L.M. Coussens, B. Fingleton, and L.M. Matrisian Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295 2002 2387 2392
31. A. Crozat, P. Aman, N. Mandahl, and D. Ron Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma Nature 363 1993 640 644
32. S. Dalal Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing's sarcoma family Clin. Cancer Res. 11 2005 2364 2378
33. L. Dauphinot Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2 and c-Myc expression Oncogene 20 2001 3258 3265
34. E. de Alava, and W.L. Gerald Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family J. Clin. Oncol. 18 2000 204 213
35. E. de Alava EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma J. Clin. Oncol. 16 1998 1248 1255
36. J.P. de Chadarevian, M. Vekemans, and T.A. Seemayer Reciprocal translocation in small-cell sarcomas N. Engl. J. Med. 311 1984 1702 1703
37. O. Delattre Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours Nature 359 1992 162 165
38. B. Deneen, and C.T. Denny Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation Oncogene 20 2001 6731 6741
39. B. Deneen, S.M. Welford, T. Ho, F. Hernandez, I. Kurland, and C.T. Denny PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins Mol. Cell. Biol. 23 2003 3897 3908
40. C.T. Denny Ewing's sarcoma-a clinical enigma coming into focus J. Pediatr. Hematol./Oncol. 20 1998 421 425
41. R. Derynck, R.J. Akhurst, and A. Balmain TGF-beta signaling in tumor suppression and cancer progression Nat. Genet. 29 2001 117 129
42. F. de Vathaire Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment Br. J. Cancer 79 1999 1884 1893
43. J.A. Diehl Cycling to cancer with cyclin D1 Cancer Biol. Ther. 1 2002 226 231
44. E.C. Douglass, M. Valentine, A.A. Green, F.A. Hayes, and E.I. Thompson t(11;22) and other chromosomal rearrangements in Ewing's sarcoma J. Natl. Cancer Inst. 77 1986 1211 1215
45. B.J. Druker Imatinib as a paradigm of targeted therapies Adv. Cancer Res. 91 2004 1 30
46. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat. Rev., Cancer 2 2002 161 174
47. J. Ewing Diffuse endothelioma of bone Proc. N.Y. Pathol. Soc. 21 1921 17 24
48. N. Ferrara Vascular endothelial growth factor: basic science and clinical progress Endocr. Rev. 25 2004 581 611
49. G. Finkenzeller, A. Sparacio, A. Technau, D. Marme, and G. Siemeister Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression Oncogene 15 1997 669 676
50. S.M. Firth, and R.C. Baxter Cellular actions of the insulin-like growth factor binding proteins Endocr. Rev. 23 2002 824 854
51. J.F. Fraumeni Jr., and A.G. Glass Rarity of Ewing's sarcoma among U.S. Negro children Lancet 1 1970 366 367
52. M. Fu, C. Wang, Z. Li, T. Sakamaki, and R.G. Pestell Cyclin D1: normal and abnormal functions Endocrinology 145 2004 5439 5447
53. B. Fuchs, C.Y. Inwards, and R. Janknecht Upregulation of the matrix metalloproteinase-1 gene by the Ewing's sarcoma associated EWS-ER81 and EWS-Fli-1 oncoproteins, c-Jun and p300 FEBS Lett. 553 2003 104 108
54. B. Fuchs, R.G. Valenzuela, C. Inwards, F.H. Sim, and M.G. Rock Complications in long-term survivors of Ewing sarcoma Cancer 98 2003 2687 2692
55. B. Fuchs, C. Inwards, S.P. Scully, and R. Janknecht hTERT Is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins Clin. Orthop. Relat. Res. 426 2004 64 68
56. B. Fuchs, C.Y. Inwards, and R. Janknecht Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma Clin. Cancer Res. 10 2004 1344 1353
57. M. Fukuma, H. Okita, J. Hata, and A. Umezawa Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma Oncogene 22 2003 1 9
58. D.M. Gascoyne, G.R. Thomas, and D.S. Latchman The effects of Brn-3a on neuronal differentiation and apoptosis are differentially modulated by EWS and its oncogenic derivative EWS/Fli-1 Oncogene 23 2004 3830 3840
59. L. Girnita, A. Girnita, M. Wang, J.M. Meis-Kindblom, L.G. Kindblom, and O. Larsson A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells Oncogene 19 2000 4298 4301
60. A. Goel, and R. Janknecht Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu Mol. Cell. Biol. 23 2003 6243 6254
61. A. Goel, and R. Janknecht Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu J. Biol. Chem. 279 2004 14909 14916
62. B.J. Graves, and J.M. Petersen Specificity within the ets family of transcription factors Adv. Cancer Res. 75 1998 1 55
63. H.E. Grier The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors Pediatr. Clin. North Am. 44 1997 991 1004
64. A. Grimberg Mechanisms by which IGF-I may promote cancer Cancer Biol. Ther. 2 2003 630 635
65. H. Guan, S.F. Jia, Z. Zhou, J. Stewart, and E.S. Kleinerman Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo Clin. Cancer Res. 11 2005 2008 2017
66. H. Guan, Z. Zhou, H. Wang, S.F. Jia, W. Liu, and E.S. Kleinerman A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model Clin. Cancer Res. 11 2005 2662 2669
67. K.B. Hahm Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein Nat. Genet. 23 1999 222 227
68. M. Hallier, A. Lerga, S. Barnache, A. Tavitian, and F. Moreau-Gachelin The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS J. Biol. Chem. 273 1998 4838 4842
69. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
70. A.L. Harris Hypoxia-a key regulatory factor in tumour growth Nat. Rev., Cancer 2 2002 38 47
71. A.H. Hart, C.M. Corrick, M.J. Tymms, P.J. Hertzog, and I. Kola Human ERG is a proto-oncogene with mitogenic and transforming activity Oncogene 10 1995 1423 1430
72. A. Hart Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia Immunity 13 2000 167 177
73. H.W. Hense, S. Ahrens, M. Paulussen, M. Lehnert, and H. Jurgens Descriptive epidemiology of Ewing's tumor-analysis of German patients from (EI)CESS 1980-1997 Klin. Padiatr. 211 1999 271 275
74. G.G. Hicks Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death Nat. Genet. 24 2000 175 179
75. E. Hiyama, and K. Hiyama Telomerase as tumor marker Cancer Lett. 194 2003 221 233
76. P.C. Hollenhorst, D.A. Jones, and B.J. Graves Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors Nucleic Acids Res. 32 2004 5693 5702
77. G. Holzer, A. Obermair, M. Koschat, O. Preyer, R. Kotz, and K. Trieb Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumors Med. Pediatr. Oncol. 36 2001 601 604
78. H.Y. Huang Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse J. Clin. Oncol. 23 2005 548 558
79. H. Ichikawa, K. Shimizu, Y. Hayashi, and M. Ohki An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation Cancer Res. 54 1994 2865 2868
80. Y.H. Im EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene Cancer Res. 60 2000 1536 1540
81. I. Irminger-Finger, and W.C. Leung BRCA1-dependent and independent functions of BARD1 Int. J. Biochem. Cell Biol. 34 2002 582 587
82. S. Jaishankar, J. Zhang, M.F. Roussel, and S.J. Baker Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity Oncogene 18 1999 5592 5597
83. R. Janknecht Analysis of the ERK-stimulated ETS transcription factor ER81 Mol. Cell. Biol. 16 1996 1550 1556
84. R. Janknecht On the road to immortality: hTERT upregulation in cancer cells FEBS Lett. 564 2004 9 13
85. R. Janknecht, and A. Nordheim Gene regulation by Ets proteins Biochim. Biophys. Acta 1155 1993 346 356
86. I.S. Jeon A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1 Oncogene 10 1995 1229 1234
87. Y. Kaneko Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy Genes Chromosomes Cancer 15 1996 115 121
88. J. Khan Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks Nat. Med. 7 2001 673 679
89. D. Kim AKT/PKB signaling mechanisms in cancer and chemoresistance Front. Biosci. 10 2005 975 984
90. L.L. Knoop, and S.J. Baker The splicing factor U1C represses EWS/FLI-mediated transactivation J. Biol. Chem. 275 2000 24865 24871
91. L.L. Knoop, and S.J. Baker EWS/FLI alters 5′-splice site selection J. Biol. Chem. 276 2001 22317 22322
92. X.T. Kong Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript Blood 90 1997 1192 1199
93. H. Kovar Ewing's sarcoma and peripheral primitive neuroectodermal tumors after their genetic union Curr. Opin. Oncol. 10 1998 334 342
94. H. Kovar Ewing tumor biology: perspectives for innovative treatment approaches Adv. Exp. Med. Biol. 532 2003 27 37
95. H. Kovar Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor Oncogene 5 1990 1067 1070
96. H. Kovar EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro Cell Growth Differ. 7 1996 429 437
97. H. Kovar Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors Oncogene 15 1997 2225 2232
98. M. Kuroda Male sterility and enhanced radiation sensitivity in TLS(-/-) mice EMBO J. 19 2000 453 462
99. N.A. Kurpios, N.A. Sabolic, T.G. Shepherd, G.M. Fidalgo, and J.A. Hassell Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis J. Mammary Gland Biol. Neoplasia 8 2003 177 190
100. N.E. Kushlinskii, I.V. Babkina, Y.N. Solov'ev, and N.N. Trapeznikov Vascular endothelium growth factor and angiogenin in the serum of patients with osteosarcoma and Ewing's tumor Bull. Exp. Biol. Med. 130 2000 691 693
101. J.F. Kuttesch Jr. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas J. Clin. Oncol. 14 1996 2818 2825
102. Y. Labelle Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation Hum. Mol. Genet. 4 1995 2219 2226
103. M. Ladanyi EWS-FLI1 and Ewing's sarcoma: recent molecular data and new insights Cancer Biol. Ther. 1 2002 330 336
104. M. Ladanyi, and W. Gerald Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor Cancer Res. 54 1994 2837 2840
105. D.R. Ladle, and E. Frank The role of the ETS gene PEA3 in the development of motor and sensory neurons Physiol. Behav. 77 2002 571 576
106. M.A. Laing Male sexual dysfunction in mice bearing targeted mutant alleles of the PEA3 ets gene Mol. Cell. Biol. 20 2000 9337 9345
107. G. Lambert EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice Biochem. Biophys. Res. Commun. 279 2000 401 406
108. L. Landuzzi The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit Am. J. Pathol. 157 2000 2123 2131
109. A. Lasorella, T. Uo, and A. Iavarone Id proteins at the cross-road of development and cancer Oncogene 20 2001 8326 8333
110. A. Lerga Identification of an RNA binding specificity for the potential splicing factor TLS J. Biol. Chem. 276 2001 6807 6816
111. S.L. Lessnick, B.S. Braun, C.T. Denny, and W.A. May Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene Oncogene 10 1995 423 431
112. S.L. Lessnick, C.S. Dacwag, and T.R. Golub The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts Cancer Cell 1 2002 393 401
113. K.K. Li, and K.A. Lee Transcriptional activation by the Ewing's sarcoma (EWS) oncogene can be cis-repressed by the EWS RNA-binding domain J. Biol. Chem. 275 2000 23053 23058
114. F.P. Li, J.T. Tu, F.S. Liu, and E.L. Shiang Rarity of Ewing's sarcoma in China Lancet 1 1980 1255
115. P.P. Lin, R.I. Brody, A.C. Hamelin, J.E. Bradner, J.H. Healey, and M. Ladanyi Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma Cancer Res. 59 1999 1428 1432
116. J. Livet ETS gene Pea3 controls the central position and terminal arborization of specific motor neuron pools Neuron 35 2002 877 892
117. J. Luo, B.D. Manning, and L.C. Cantley Targeting the PI3K-Akt pathway in human cancer: rationale and promise Cancer Cell 4 2003 257 262
118. B. Lüscher Function and regulation of the transcription factors of the Myc/Max/Mad network Gene 277 2001 1 14
119. C.D. Mackereth, M. Scharpf, L.N. Gentile, S.E. MacIntosh, C.M. Slupsky, and L.P. McIntosh Diversity in structure and function of the Ets family PNT domains J. Mol. Biol. 342 2004 1249 1264
120. X. Mao, S. Miesfeldt, H. Yang, J.M. Leiden, and C.B. Thompson The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities J. Biol. Chem. 269 1994 18216 18222
121. A. Martini Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia Cancer Res. 62 2002 5408 5412
122. J. Massague TGF-beta signal transduction Annu. Rev. Biochem. 67 1998 753 791
123. T. Mastrangelo A novel zinc finger gene is fused to EWS in small round cell tumor Oncogene 19 2000 3799 3804
124. S. Mateo-Lozano, O.M. Tirado, and V. Notario Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation Oncogene 22 2003 9282 9287
125. Y. Matsumoto, K. Tanaka, F. Nakatani, T. Matsunobu, S. Matsuda, and Y. Iwamoto Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1) regulatory genes Br. J. Cancer 84 2001 768 775
126. T. Matsunobu The prognostic and therapeutic relevance of p27kip1 in Ewing's family tumors Clin. Cancer Res. 10 2004 1003 1012
127. P. Maurer FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain Oncogene 22 2003 3319 3329
128. W.A. May Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation Proc. Natl. Acad. Sci. U. S. A. 90 1993 5752 5756
129. W.A. May The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 Mol. Cell. Biol. 13 1993 7393 7398
130. T.W. McLean Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the dana-farber cancer institute/children's hospital experience J. Pediatr. Hematol./Oncol. 21 1999 486 493
131. M.S. Merchant Interferon gamma enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma Cancer Res. 64 2004 8349 8356
132. P.A. Meyers, and A.S. Levy Ewing's sarcoma Curr. Treatm. Opt. Oncol. 1 2000 247 257
133. C.S. Mitsiades, N. Mitsiades, and M. Koutsilieris The Akt pathway: molecular targets for anti-cancer drug development Curr. Cancer Drug Targets 4 2004 235 256
134. D. Monte, J.L. Baert, P.A. Defossez, Y. de Launoit, and D. Stehelin Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors Oncogene 9 1994 1397 1406
135. F. Morohoshi, K. Arai, E.I. Takahashi, A. Tanigami, and M. Ohki Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins Genomics 38 1996 51 77
136. D. Mukhopadhyay, B. Knebelmann, H.T. Cohen, S. Ananth, and V.P. Sukhatme The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity Mol. Cell. Biol. 17 1997 5629 5639
137. F. Nakatani Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein J. Biol. Chem. 278 2003 15105 15115
138. S.A. Narod, and W.D. Foulkes BRCA1 and BRCA2: 1994 and beyond Nat. Rev., Cancer 4 2004 665 676
139. H. Nishimori The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors Oncogene 21 2002 8302 8309
140. B. Novakovic, T.R. Fears, M.E. Horowitz, M.A. Tucker, and L.H. Wexler Late effects of therapy in survivors of Ewing's sarcoma family tumors J. Pediatr. Hematol./Oncol. 19 1997 220 225
141. R.C. O'Hagan, and J.A. Hassell The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase Oncogene 16 1998 301 310
142. R.C. O'Hagan, R.G. Tozer, M. Symons, F. McCormick, and J.A. Hassell The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades Oncogene 13 1996 1323 1333
143. A. Ohali Prediction of high risk Ewing's sarcoma by gene expression profiling Oncogene 23 2004 8997 9006
144. T. Ohno, V.N. Rao, and E.S. Reddy EWS/Fli-1 chimeric protein is a transcriptional activator Cancer Res. 53 1993 5859 5863
145. T. Ohno, M. Ouchida, L. Lee, Z. Gatalica, V.N. Rao, and E.S. Reddy The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains Oncogene 9 1994 3087 3097
146. S. O'Regan, M.F. Diebler, F.M. Meunier, and S. Vyas A Ewing's sarcoma cell line showing some, but not all, of the traits of a cholinergic neuron J. Neurochem. 64 1995 69 76
147. M. Ouchida, T. Ohno, Y. Fujimura, V.N. Rao, and E.S. Reddy Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts Oncogene 11 1995 1049 1054
148. C.M. Overall, and C. Lopez-Otin Strategies for MMP inhibition in cancer: innovations for the post-trial era Nat. Rev., Cancer 2 2002 657 672
149. I. Panagopoulos Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22) Genes Chromosomes Cancer 11 1994 256 262
150. I. Panagopoulos, M. Hoglund, F. Mertens, N. Mandahl, F. Mitelman, and P. Aman Fusion of the EWS and CHOP genes in myxoid liposarcoma Oncogene 12 1996 489 494
151. S. Papoutsopoulou, and R. Janknecht Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300 Mol. Cell. Biol. 20 2000 7300 7310
152. M. Paulussen, B. Frohlich, and H. Jurgens Ewing tumour: incidence, prognosis and treatment options Paediatr. Drugs 3 2001 899 913
153. H. Pavlakovic, V. Von Schutz, J. Rossler, E. Koscielniak, W. Havers, and L. Schweigerer Quantification of angiogenesis stimulators in children with solid malignancies Int. J. Cancer 92 2001 756 760
154. S. Pelengaris, M. Khan, and G. Evan c-MYC: more than just a matter of life and death Nat. Rev., Cancer 2 2002 764 776
155. E.J. Perlman, P.S. Dickman, F.B. Askin, H.E. Grier, J.S. Miser, and M.P. Link Ewing's sarcoma-routine diagnostic utilization of MIC2 analysis: a pediatric oncology group/children's cancer group intergroup study Human Pathol. 25 1994 304 307
156. M. Peter, F. Mugneret, A. Aurias, G. Thomas, H. Magdelenat, and O. Delattre An EWS/ERG fusion with a truncated N-terminal domain of EWS in a Ewing's tumor Int. J. Cancer 67 1996 339 342
157. M. Peter A new member of the ETS family fused to EWS in Ewing tumors Oncogene 14 1997 1159 1164
158. M. Peter, E. Gilbert, and O. Delattre A multiplex real-time pcr assay for the detection of gene fusions observed in solid tumors Lab. Invest. 81 2001 905 912
159. R. Petermann, B.M. Mossier, D.N. Aryee, V. Khazak, E.A. Golemis, and H. Kovar Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II Oncogene 17 1998 603 610
160. C. Pfleiderer Detection of tumour cells in peripheral blood and bone marrow from Ewing tumour patients by RT-PCR Int. J. Cancer 64 1995 135 139
161. B. Plougastel, J. Zucman, M. Peter, G. Thomas, and O. Delattre Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation Genomics 18 1993 609 615
162. M.N. Pollak, E.S. Schernhammer, and S.E. Hankinson Insulin-like growth factors and neoplasia Nat. Rev., Cancer 4 2004 505 518
163. C.A. Powers, M. Mathur, B.M. Raaka, D. Ron, and H.H. Samuels TLS (translocated-in-liposarcoma) is a high-affinity interactor for steroid, thyroid hormone, and retinoid receptors Mol. Endocrinol. 12 1998 4 18
164. A. Prieur, F. Tirode, P. Cohen, and O. Delattre EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3 Mol. Cell. Biol. 24 2004 7275 7283
165. X. Qian, L. Jin, B.M. Shearer, R.P. Ketterling, S.M. Jalal, and R.V. Lloyd Molecular Diagnosis of Ewing's Sarcoma/Primitive Neuroectodermal Tumor in Formalin-Fixed Paraffin-Embedded Tissues by RT-PCR and Fluorescence In Situ Hybridization Diagn. Mol. Pathol. 14 2005 23 28
166. T.H. Rabbitts, A. Forster, R. Larson, and P. Nathan Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma Nat. Genet. 4 1993 175 180
167. R. Ramakrishnan Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1 Oncogene 23 2004 7087 7094
168. V.N. Rao, T. Ohno, D.D. Prasad, G. Bhattacharya, and E.S. Reddy Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein Oncogene 8 1993 2167 2173
169. R.D. Rao, J.C. Buckner, and J.N. Sarkaria Mammalian target of rapamycin (mTOR) inhibitors as anti-cancer agents Curr. Cancer Drug Targets 4 2004 621 635
170. F.J. Ruscher III, L.E. Benjamin, W.J. Fredericks, and J.F. Morris Novel oncogenic mutations in the WT1 Wilms' tumor suppressor gene: a t(11;22) fuses the Ewing's sarcoma gene, EWS1, to WT1 in desmoplastic small round cell tumor Cold Spring Harbor. Symp. Quant. Biol. 59 1994 137 146
171. E. Ricotti c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells Blood 91 1998 2397 2405
172. R.D. Riley A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family Eur. J. Cancer 39 2003 19 30
173. C. Rodriguez-Galindo, S.L. Spunt, and A.S. Pappo Treatment of Ewing sarcoma family of tumors: current status and outlook for the future Med. Pediatr. Oncol. 40 2003 276 287
174. C.J. Rorie, V.D. Thomas, P. Chen, H.H. Pierce, J.P. O'Bryan, and B.E. Weissman The Ews/Fli-1 fusion gene switches the differentiation program of neuroblastomas to Ewing sarcoma/peripheral primitive neuroectodermal tumors Cancer Res. 64 2004 1266 1277
175. K.L. Rossow, and R. Janknecht The Ewing's sarcoma gene product functions as a transcriptional activator Cancer Res. 61 2001 2690 2695
176. M.B. Ruzinova, and R. Benezra Id proteins in development, cell cycle and cancer Trends Cell Biol. 13 2003 410 418
177. K. Scotlandi Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice Cancer Res. 58 1998 4127 4131
178. K. Scotlandi Murine model for skeletal metastases of Ewing's sarcoma J. Orthop. Res. 18 2000 959 966
179. K. Scotlandi Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells Cancer Gene Ther. 9 2002 296 307
180. A. Sekyi-Otu, R.S. Bell, C. Ohashi, M. Pollak, and I.L. Andrulis Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas Cancer Res. 55 1995 129 134
181. A.D. Sharrocks The ETS-domain transcription factor family Nat. Rev., Mol. Cell Biol. 2 2001 827 837
182. K. Shimizu An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation Proc. Natl. Acad. Sci. U. S. A. 90 1993 10280 10284
183. D.C. Shing FUS/ERG gene fusions in Ewing's tumors Cancer Res. 63 2003 4568 4576
184. H.R. Siddique, V.N. Rao, L. Lee, and E.S. Reddy Characterization of the DNA binding and transcriptional activation domains of the erg protein Oncogene 8 1993 1751 1755
185. C. Siligan EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin Oncogene 24 2005 2512 2524
186. H. Sjogren, J. Meis-Kindblom, L.G. Kindblom, P. Aman, and G. Stenman Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma Cancer Res. 59 1999 5064 5067
187. B.E. Smithey, A.S. Pappo, and D.A. Hill C-kit expression in pediatric solid tumors: a comparative immunohistochemical study Am. J. Surg. Pathol. 26 2002 486 492
188. P.H. Sorensen, S.L. Lessnick, D. Lopez-Terrada, X.F. Liu, T.J. Triche, and C.T. Denny A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG Nat. Genet. 6 1994 146 151
189. L. Spahn, R. Petermann, C. Siligan, J.A. Schmid, D.N. Aryee, and H. Kovar Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway Cancer Res. 62 2002 4583 4587
190. L. Spahn, C. Siligan, R. Bachmaier, J.A. Schmid, D.N. Aryee, and H. Kovar Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein Oncogene 22 2003 6819 6829
191. D.D. Spyropoulos Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor Mol. Cell. Biol. 20 2000 5643 5652
192. M.S. Staege DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets Cancer Res. 64 2004 8213 8221
193. C.A. Stiller, and D.M. Parkin Geographic and ethnic variations in the incidence of childhood cancer Br. Med. Bull. 52 1996 682 703
194. R. Strammiello Impact of IGF-I/IGF-IR circuit on the angiogenetic properties of Ewing's sarcoma cells Horm. Metab. Res. 35 2003 675 684
195. G. Suske The Sp-family of transcription factors Gene 238 1999 291 300
196. A. Takahashi EWS/ETS fusions activate telomerase in Ewing's tumors Cancer Res. 63 2003 8338 8344
197. K. Tanaka, T. Iwakuma, K. Harimaya, H. Sato, and Y. Iwamoto EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells J. Clin. Invest. 99 1997 239 247
198. A.D. Thompson, M.A. Teitell, A. Arvand, and C.T. Denny Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells Oncogene 18 1999 5506 5513
199. J.A. Toretsky, Y. Connell, L. Neckers, and N.K. Bhat Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides J. Neuro-oncol. 31 1997 9 16
200. J.A. Toretsky, T. Kalebic, V. Blakesley, D. LeRoith, and L.J. Helman The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts J. Biol. Chem. 272 1997 30822 30827
201. C. Turc-Carel, I. Philip, M.P. Berger, T. Philip, and G. Lenoir Chromosomal translocation in Ewing's sarcoma N. Engl. J. Med. 309 1983 497 498
202. C. Turc-Carel, I. Philip, M.P. Berger, T. Philip, and G.M. Lenoir Chromosome study of Ewing's sarcoma (ES) cell lines. Consistency of a reciprocal translocation t(11;22)(q24;q12) Cancer Genet. Cytogenet. 12 1984 1 19
203. H. Uranishi Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator J. Biol. Chem. 276 2001 13395 13401
204. F. Urano, A. Umezawa, W. Hong, H. Kikuchi, and J. Hata A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma Biochem. Biophys. Res. Commun. 219 1996 608 612
205. A. Uren Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells Oncogene 22 2003 2334 2342
206. N.V. Vigfusson, L.J. Allen, J.H. Phillips, T. Alschibaja, and W.G. Riches A neuroendocrine tumor of the small intestine with a karyotype of 46, XY,t(11;22) Cancer Genet. Cytogenet. 22 1986 211 218
207. D.H. Wai Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays Int. J. Oncol. 20 2002 441 451
208. M. Wanzel, S. Herold, and M. Eilers Transcriptional repression by Myc Trends Cell Biol. 13 2003 146 150
209. B. Wasylyk, S.L. Hahn, and A. Giovane The Ets family of transcription factors Eur. J. Biochem. 211 1993 7 18
210. K.L. Weber Current concepts in the treatment of Ewing's sarcoma Expert Rev. Anticancer Ther. 2 2002 687 694
211. S.M. Welford Detection of differentially expressed genes in primary tumor tissues using representational differences analysis coupled to microarray hybridization Nucleic Acids Res. 26 1998 3059 3065
212. S.M. Welford, S.P. Hebert, B. Deneen, A. Arvand, and C.T. Denny DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis J. Biol. Chem. 276 2001 41977 41984
213. D.C. West, H.E. Grier, M.M. Swallow, G.D. Demetri, L. Granowetter, and J. Sklar Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor J. Clin. Oncol. 15 1997 583 588
214. J. Whang-Peng, T.J. Triche, T. Knutsen, J. Miser, E.C. Douglass, and M.A. Israel Chromosome translocation in peripheral neuroepithelioma N. Engl. J. Med. 311 1984 584 585
215. J. Whang-Peng Cytogenetic characterization of selected small round cell tumors of childhood Cancer Genet. Cytogenet. 21 1986 185 208
216. J. Whang-Peng, C.E. Freter, T. Knutsen, J.J. Nanfro, and A. Gazdar Translocation t(11;22) in esthesioneuroblastoma Cancer Genet. Cytogenet. 29 1987 155 157
217. H. Yabe Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo Biochem. Biophys. Res. Commun. 293 2002 61 71
218. S. Yamaguchi, Y. Yamazaki, Y. Ishikawa, N. Kawaguchi, H. Mukai, and T. Nakamura EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12) Genes Chromosomes Cancer 43 2005 217 222
219. L. Yang, H.A. Chansky, and D.D. Hickstein EWS.Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing J. Biol. Chem. 275 2000 37612 37618
220. H. Yi, Y. Fujimura, M. Ouchida, D.D. Prasad, V.N. Rao, and E.S. Reddy Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias Oncogene 14 1997 1259 1268
221. J.L. Young Jr., and R.W. Miller Incidence of malignant tumors in U.S. children J. Pediatr. 86 1975 254 258
222. Z. Zebedee, and E. Hara Id proteins in cell cycle control and cellular senescence Oncogene 20 2001 8317 8325
223. D. Zhang, A.J. Paley, and G. Childs The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription J. Biol. Chem. 273 1998 18086 18091
224. H. Zinszner, R. Albalat, and D. Ron A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP Genes Dev. 8 1994 2513 2526
225. H. Zinszner, J. Sok, D. Immanuel, Y. Yin, and D. Ron TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling J. Cell. Sci. 110 1997 1741 1750
226. A. Zoubek Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J. Clin. Oncol. 14 1996 1245 1251
227. A. Zoubek Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT-PCR: a preliminary evaluation Int. J. Cancer 79 1998 56 60
228. J. Zucman Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints Genes Chromosomes Cancer 5 1992 271 277
229. J. Zucman EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts Nat. Genet. 4 1993 341 345
230. J. Zucman Combinatorial generation of variable fusion proteins in the Ewing family of tumours EMBO J. 12 1993 4481 4487
231. J. Zucman-Rossi, M.A. Batzer, M. Stoneking, O. Delattre, and G. Thomas Interethnic polymorphism of EWS intron 6: genome plasticity mediated by Alu retroposition and recombination Hum. Genet. 99 1997 357 363
232. J.P. Zwerner, and W.A. May PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors Oncogene 20 2001 626 633